These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1442174)
21. Role of IFN gamma on TNF alpha, IL-1 beta and IL-6 release during HHV-6 infection. Arena A; Capozza AB; Di Luca D New Microbiol; 1996 Jul; 19(3):183-91. PubMed ID: 8841033 [TBL] [Abstract][Full Text] [Related]
22. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. Chong AS; Scuderi P; Grimes WJ; Hersh EM J Immunol; 1989 Mar; 142(6):2133-9. PubMed ID: 2493506 [TBL] [Abstract][Full Text] [Related]
23. Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy. Mier JW; Brandon EP; Libby P; Janicka MW; Aronson FR J Immunol; 1989 Oct; 143(7):2407-14. PubMed ID: 2528594 [TBL] [Abstract][Full Text] [Related]
24. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals. Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270 [TBL] [Abstract][Full Text] [Related]
25. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro. Ghoneum M; Jewett A Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563 [TBL] [Abstract][Full Text] [Related]
26. Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro. Ujiie T Jpn J Exp Med; 1987 Dec; 57(6):333-8. PubMed ID: 3131563 [TBL] [Abstract][Full Text] [Related]
27. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma. Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875 [TBL] [Abstract][Full Text] [Related]
28. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab. Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433 [TBL] [Abstract][Full Text] [Related]
29. IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes: involvement in IL-12 and IFN-gamma production in PBMC. Yoshida A; Takahashi HK; Nishibori M; Iwagaki H; Yoshino T; Morichika T; Yokoyama M; Kondo E; Akagi T; Tanaka N Cell Immunol; 2001 Jun; 210(2):106-15. PubMed ID: 11520077 [TBL] [Abstract][Full Text] [Related]
30. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma). Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283 [TBL] [Abstract][Full Text] [Related]
31. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients. de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753 [TBL] [Abstract][Full Text] [Related]
32. Human peripheral blood gamma delta T cells are uniformly sensitive to destruction by the lysosomotropic agents leucine methyl ester and leucyl leucine methyl ester. Pechhold K; Kabelitz D Eur J Immunol; 1993 Feb; 23(2):562-5. PubMed ID: 8436187 [TBL] [Abstract][Full Text] [Related]
33. Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells. Faget J; Biota C; Bachelot T; Gobert M; Treilleux I; Goutagny N; Durand I; Léon-Goddard S; Blay JY; Caux C; Ménétrier-Caux C Cancer Res; 2011 Oct; 71(19):6143-52. PubMed ID: 21852386 [TBL] [Abstract][Full Text] [Related]
34. [Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma]. Tsunoda T; Tanimura H; Yamaue H; Tani M; Iwahashi M Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1110-8. PubMed ID: 2118938 [TBL] [Abstract][Full Text] [Related]
35. Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma. Tsunoda T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tamai M; Noguchi K; Arii K; Hotta T Nihon Geka Hokan; 1991 Nov; 60(6):396-405. PubMed ID: 1820012 [TBL] [Abstract][Full Text] [Related]
36. Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin 2-activated killer cells. Ausiello CM; Palma C; Spagnoli GC; Piazza A; Casciani CU; Cassone A Cell Immunol; 1989 Jul; 121(2):349-59. PubMed ID: 2661020 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. Puren AJ; Fantuzzi G; Gu Y; Su MS; Dinarello CA J Clin Invest; 1998 Feb; 101(3):711-21. PubMed ID: 9449707 [TBL] [Abstract][Full Text] [Related]
38. IL-12-mediated activation of MHC-unrestricted cytotoxicity of human PBMC subpopulations: synergic action of a plant rhamnogalacturonan. Klein-Franke A; Anderer FA Anticancer Res; 1995; 15(6B):2511-6. PubMed ID: 8669815 [TBL] [Abstract][Full Text] [Related]
39. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation. Okamoto M; Gohda H; Ohe G; Yoshida H; Matsuno T; Saito M; Sato M J Immunother; 2000 Jan; 23(1):94-103. PubMed ID: 10687142 [TBL] [Abstract][Full Text] [Related]
40. Activation of natural killer cells and cytokine production in man by bacterial extracts. Wybran J; Libin M; Schandene L Immunopharmacol Immunotoxicol; 1989; 11(1):17-32. PubMed ID: 2503554 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]